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Abstract 
Background: To determine the frequency of, and factors associated with, death in hospital following ICU discharge 
to the ward.
Methods: The Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE study 
was an international, multicenter, prospective cohort study of patients with severe respiratory failure, conducted 
across 459 ICUs from 50 countries globally. This study aimed to understand the frequency and factors associated with 
death in hospital in patients who survived their ICU stay. We examined outcomes in the subpopulation discharged 
with no limitations of life sustaining treatments (‘treatment limitations’), and the subpopulations with treatment 
limitations.
Results: 2186 (94%) patients with no treatment limitations discharged from ICU survived, while 142 (6%) died in 
hospital. 118 (61%) of patients with treatment limitations survived while 77 (39%) patients died in hospital. Patients 
without treatment limitations that died in hospital after ICU discharge were older, more likely to have COPD, immu-
nocompromise or chronic renal failure, less likely to have trauma as a risk factor for ARDS. Patients that died post ICU 
discharge were less likely to receive neuromuscular blockade, or to receive any adjunctive measure, and had a higher 
pre- ICU discharge non-pulmonary SOFA score. A similar pattern was seen in patients with treatment limitations that 
died in hospital following ICU discharge.
Conclusions: A significant proportion of patients die in hospital following discharge from ICU, with higher mortality 
in patients with limitations of life-sustaining treatments in place. Non-survivors had higher systemic illness severity 
scores at ICU discharge than survivors.
Trial Registration: ClinicalTrials.gov NCT02 010073.
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Background
Patients that are discharged alive from the ICU are 
often considered to have ‘survived’ their critical illness, 
and to be in the recovery phase. However, this is now 
understood that these patients suffer ongoing increased 
morbidity and mortality following the acute phase of 
their critical illness. Indeed, one might view ICU survival 
as one—albeit major—of a series of hurdles in a recovery 
process from critical illness that can take several years. 
Elegant long-term follow-up studies, such as those con-
ducted by Herridge and colleagues, show substantial 
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In contrast, relatively little is known about the sub-
group of patients that are discharged to the ward from 
the ICU, but subsequently die in hospital prior to dis-
charge. Of particular interest is the identification of 
potentially modifiable factors associated with in-hos-
pital death in these patients. Patients discharged from 
ICU can be considered to fall into 2 groups, depend-
ing on whether limitations regarding life-sustaining 
treatments (referred to as ‘treatment limitations’) 
were placed at the time of discharge [2, 3]. Patients in 
whom treatment limitations were in place are generally 
considered to have a more guarded prognosis, while 
patients without such treatment limitations are thought 
to have a better prognosis [2, 3].
Given these issues, we wished to examine the fre-
quency and factors associated with death in hospital 
following ICU discharge in patients enrolled into The 
Large observational study to UNderstand the Global 
impact of Severe Acute respiratory FailurE (LUNG 
SAFE) study, a prospective cohort study undertaken in 
459 Intensive Care Units (ICUs) in 50 countries across 
5 continents [4]. LUNG SAFE constitutes the larg-
est cohort available of patients with acute hypoxaemic 
respiratory failure requiring ventilatory support. The 
wide geographic spread of participating ICUs, and the 
large patient sample size are important strengths of this 
study [4]. In this secondary and explorative analysis of 
LUNG SAFE, our primary objective was to determine 
the percentage of patients dying in hospital following 
ICU discharge, in patients with and without treatment 
limitation decisions in place. Secondary objectives 
included description of factors associated with death 
in both patient subgroups, with a particular focus on 
identifying risk factors (some of which are potentially 
modifiable) and related to patient management.
Methods and materials
Study design
The detailed methods and protocol have been pub-
lished elsewhere [4]. In brief, LUNG SAFE was an inter-
national, multicentre, prospective cohort study, with 
a 4-week enrolment window in the winter season [4]. 
The study, funded by the European Society of Inten-
sive Care Medicine (ESICM), was endorsed by multiple 
national societies/networks (Acknowledgements). All 
participating ICUs obtained ethics committee approval, 
and either patient consent or ethics committee waiver 
of consent. National coordinators (Acknowledgements) 
and site investigators (Acknowledgements) were 
responsible for obtaining ethics committee approval 
and for ensuring data integrity and validity.
Study population
The study inclusion criteria for acute respiratory hypox-
emic failure (AHRF) were: a  PaO2/FIO2 of 300  mmHg 
or less; new pulmonary infiltrates on chest imaging, and 
requirement of ventilatory support with a positive end-
expiratory pressure (PEEP) of 5 cm  H2O or more. Exclu-
sion criteria were: age < 16  years or inability to obtain 
informed consent, where required. The study population 
consisted of patients fulfilling criteria for AHRF that sur-
vived their ICU stay and were discharged to a hospital 
ward within 90 days of ICU admission). The study popu-
lation was divided into 2 groups, depending on whether 
or not the patient has a decision to limit life-sustaining 
measures (Fig. 1).
Data definitions
Our data definitions have been previously reported [4]. In 
the present study, ICU and hospital survival were evalu-
ated at ICU or hospital discharge, or at day 90, whichever 
occurred first. For the geo-economic area definition, we 
used the classification we have previously reported [5].
Data management and statistical analyses
Descriptive statistics included proportions for categorical 
and mean (standard deviation) or median (interquartile 
range) for continuous variables. The amount of missing 
data was low as previously reported [4], and no assump-
tions were made for missing data. Statistical differences 
in proportions observed in the groups (treatment limi-
tation, no treatment limitation) were assessed with chi-
square test, or Fisher exact test according to number of 
expected cases. Continuous variables were compared 
using T-test or Wilcoxon rank sum test, according to 
Normal data distribution. Shapiro-Wilks test was used to 
assess normality in data distribution.
In order to assess statistical difference between param-
eters observed at ICU admission and discharge, we used 
Wilcoxon signed-rank test accounting for the paired 
nature of the data not normally distributed.
Logistic regression models were applied in order to 
identify predictors of hospital mortality in patients with-
out treatment limitation. A stepwise approach was used 
to detect predictor of hospital mortality after ICU dis-
charge. This approach combines forward and backward 
selection methods in an iterative procedure (significance 
level of 0.05 both for entry and retention). Potential inde-
pendent predictors were: patient characteristics at base-
line (age, sex, BMI, geo-economic area), chronic disease 
(chronic obstructive pulmonary disease (COPD), dia-
betes mellitus, immuno-incompetence, cardiac failure, 
renal failure, liver failure), presence of ARDS risk fac-
tors, ICU characteristics (number of beds, proportion 
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of ICU beds in hospital, number of beds per physician 
and per nurse, academic ICU), illness severity param-
eters evaluated at last available day in ICU  (PaO2/FiO2, 
 PaCO2, pH, SOFA score adjusted for missing values). 
Results were reported as odds ratio with 95% confidence 
interval. Same approach was used on patients on invasive 
mechanical ventilation for at least two days during ICU 
stay in order to assess the possible association between 
ventilator parameters and hospital mortality (after ICU 
discharge). The list of possible independent variables 
used in stepwise approach also included ventilator setting 
observed during the last available day of IMV. Same anal-
ysis was performed on patients with a treatment limita-
tion during ICU stay.
The Kaplan–Meier approach was applied to assess the 
probability of hospital survival after ICU discharge, con-
sidering censored those patients discharged alive from 
hospital, as well as those patients with a hospital dis-
charge after 60  days from ICU discharge. The log-rank 
test was used to compare survival curves estimated in 
patients with or without treatment limitation. Same 
approach was used to assess probability of hospital sur-
vival in study population stratified in 3 groups: patients 
with a treatment limitation, patients without a treatment 
limitation and adjunctive measures used during ICU stay, 
patients without a treatment limitation and no adjunctive 
measures.
All p values were two-sided, with p values < 0.05 con-
sidered as statistically significant. Statistical analyses 
were performed with R, version 3.5.2 (The R Foundation 
for Statistical Computing) and SAS software, version 9.4 
(SAS Institute, Cary, NC, USA).
Results
A total of 4499 patients had AHRF defined by a  PaO2/
FIO2 of 300  mmHg or less, new pulmonary infiltrates 
on chest imaging, and requirement of ventilator support 
with a PEEP of 5 cm  H2O or more (Fig. 1). Of these, 3058 
(68%) survived to ICU discharge. Of these, 2814 (92%) 
did not have any treatment limitations in place, while 244 
patients (8%) did have limitations in place.
Death in hospital post‑ICU discharge
2186 (94%) of patients without treatment limitations 
survived to hospital discharge, while 142 (6.1%) died in 
hospital (Fig.  1). 118 (61%) of patients with treatment 
limitations survived, while 77 (39%) patients died in hos-
pital. Of the 39 patients (20%) with treatment limitations 
Fig. 1 Flowchart of study population subdivided into the patient groups with and without treatment limitations
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placed on (36 patients) or before (3 patients) ICU admis-
sion, 12 died (32%). Of the 145 patients (74%) that had 
treatment limitations in place after the day of ICU admis-
sion, 62 (43%) died in hospital following ICU discharge. 
11 patients had date of limitation not available, of whom 
3 died (27%). There were no significant differences in 
hospital mortality rates (p = 0.18).
Patients that died in hospital after ICU discharge dif-
fered in a number of potentially important respects from 
those that survived (Table 1) being older, more likely to 
have COPD, immunocompromise or chronic renal failure 
and less likely to have trauma as a risk factor for ARDS.
Illness severity factors
Patients with no treatment limitations who died in hos-
pital following ICU discharge had higher organ injury 
severity scores (Fig.  2a) compared to survivors, at both 
ICU admission and at ICU discharge (Table  2). SOFA 
scores at first day of AHRF and at last available day in 
ICU were higher in patients that died in hospital after 
ICU discharge (Table 2). This seemed to be driven by the 
non-pulmonary components of the SOFA score (Fig. 2b), 
as pulmonary organ injury severity scores did not differ 
between survivors and non-survivors in those without 
treatment limitations. Specifically, there was no differ-
ence in P/F or PaCO2 on initial or last day between sur-
vivors and non-survivors (Fig.  2c, d). In addition, there 
was no difference in the proportion of patient with ARDS 
among those that survived versus those that died follow-
ing ICU discharge (Table 1).
In contrast, patients with treatment limitations who 
died in hospital following ICU discharge had comparable 
systemic organ injury severity scores (Additional file  1: 
Figure e1A-B), but higher pulmonary organ injury sever-
ity scores (Additional file 1: Figure e1C-D) compared to 
survivors, at both ICU admission and at ICU discharge. 
ARDS recognition was lower (Additional file 1: Table S1) 
in non-survivors compared to survivors.
Patient management factors
Patients with no treatment limitations that survived to 
hospital discharge received higher levels of PEEP on the 
first day of invasive MV (Table 3). In contrast, on the last 
day of assisted ventilation in the ICU, both surviving and 
non-surviving patients with no treatment limitations 
required similar levels of ventilatory support (Table  3). 
Specifically, last day  FiO2 (Fig.  3a) and peak initiatory 
pressures (Fig.  3b) were lower, while tidal volume, res-
piratory rates, dynamic compliance and minute volumes 
(Fig.  3c–f) were similar, in comparison to hospital sur-
vivors. Furthermore, there were no differences in the 
length of ICU stay between survivors and non-survivors, 
although the proportion of patients with long ICU stays 
was numerically higher in patients that survived post-
ICU discharge (Table 1). 
Similar patterns were seen in patients with treatment 
limitations who died in hospital (Additional file  1: Fig-
ure e2A-F). Patients with treatment limitations who died 
post ICU discharge had shorter ICU stays compared to 
those that survived (Additional file 1: Table S1).
Impact of adjunctive therapies
The frequency of neuromuscular blockade use, and of 
any adjunctive treatment was reduced in patients who 
died in hospital following ICU discharge (Table  4). Use 
adjunctive measures was independently associated with 
reduced hospital mortality in a multivariate logistic 
regression model (Table 5).
Impact of geo‑economic area
Patients from the Non-European-high income area with 
no treatment limitations had higher SOFA scores at 
ICU discharge than patients from Europe or from Mid-
dle Income countries (Table 5). However, SOFA scores at 
day 10 post ICU admission were not different across the 
regions. In patients without treatment limitations, ward 
mortality ratios were not different (p = 0.2086) between 
geographic areas (Table  1). In patients with treatment 
limitations of LSMs, ward mortality ratios were signifi-
cantly lower in middle income countries (17.2%) com-
pared to both European-High (41.5%; p = 0.0160) and 
Non-European-High (46.7%, p = 0.0071) income coun-
tries (Table 1 and Additional file 1: Table S1).
Factors associated with hospital death post ICU discharge
Length of ICU stay was similar in patients who survived 
to hospital discharge and those that died, in patients 
without treatment limitations (Fig.  4a). In contrast, 
patients with treatment limitations who died post ICU 
discharge had shorter ICU stays compared to those 
that survived (Additional file  1: Table  S1). Hospital sur-
vival rates post ICU discharge were significantly lower 
in patients that had treatment limitations, compared to 
those with no limitations (Fig.  4b). In patients without 
treatment limitations, there were more deaths following 
ICU discharge in patients who received no adjunctive 
treatment as part of their ARDS management (Fig.  4c). 
The majority deaths for patients with limitations in life-
sustaining therapies occurred within 10 days of discharge 
from the ICU (Fig. 4b).
In a multivariate logistic regression model Factors asso-
ciated with increased hospital mortality in patients with 
no limitations of life sustaining measures included age, 
adjusted SOFA score on the last available day in ICU, and 
immune-incompetence. Duration of ICU stay was also 
associated with hospital mortality post ICU discharge in 
Page 5 of 17Madotto et al. Crit Care          (2021) 25:144  
Table 1 Characteristics of study subpopulation with no treatment limitations at ICU discharge according to vital status at hospital 
discharge.
ARDS acute respiratory distress syndrome, BMI body mass index, COPD chronic obstructive pulmonary disease, ICU intensive care unit, IQR interquartile range [first and 
third quartile], SD standard deviation
a Sum of percentages is greater than 100%, because patient could have more than one chronic disease/risk factor.
Alive N = 2186 Dead N = 142 Total N = 2328 p value
Male, n (%) 1363 (62.35) 93 (65.49) 1,456 (62.49) 0.4536
Age (years), mean ± SD 60.03 ± 16.34 68.70 ± 15.71 60.56 ± 16.43 < .0001
Geographic area 0.2086
 European high income countries 1207 (55.22) 88 (61.97) 1295 (55.63)
 Non-European high income countries 655 (29.96) 33 (23.24) 688 (29.55)
 Middle income countries 324 (14.82) 21 (14.79) 345 (14.82)
BMI (kg/m2), mean ± SD 27.92 ± 7.72 26.57 ± 6.03 27.84 ± 7.63 0.1389
Length of ICU stay (days) from AHRF onset, median [IQR] 8.00 [5.00–16.00] 10.00 [6.00–16.00] 9.00 [5.00–16.00] 0.1162
Length of ICU stay > 28 days from AHRF onset, n (%) 226 (10.34) 8 (5.63) 234 (10.05) 0.0708
Length of ICU stay (days) from admission, median [IQR] 10.00 [5.00–18.00] 10.50 [7.00–18.00] 10.00 [6.00–18.00] 0.0984
ARDS during ICU stay, n (%) 1414 (64.68) 93 (65.49) 1507 (64.73) 0.8451
Clinical recognition of ARDS during ICU stay, n (%) 925 (42.31) 61 (42.96) 986 (42.35) 0.8806
Chronic  diseasea, n (%)
 COPD 492 (22.51) 43 (30.28) 535 (22.98) 0.0328
 Diabetes mellitus 501 (22.92) 36 (25.35) 537 (23.07) 0.5047
 Immune-incompetence (all-types) 344 (15.74) 40 (28.17) 384 (16.49) 0.0001
 Chronic cardiac failure 241 (11.02) 19 (13.38) 260 (11.17) 0.3878
 Chronic renal failure 229 (10.48) 23 (16.10) 252 (10.82) 0.0335
 Chronic liver failure 42 (1.92) 5 (3.52) 47 (2.02) 0.2054
Risk factors for ARDS, n (%) 0.3586
 None 373 (17.06) 22 (15.49) 385 (16.97)
 Only non-pulmonary 448 (20.49) 36 (25.35) 484 (20.79)
 Only pulmonary 1110 (50.32) 72 (50.70) 1172 (50.34)
Both 265 (12.12) 12 (8.45) 277 (11.90)
Risk factors for  ARDSa, n (%)
 Pneumonia 1089 (49.82) 78 (54.93) 1167 (50.13) 0.2377
 Extra-pulmonary sepsis 301 (13.77) 16 (18.31) 327 (14.05) 0.1313
 Aspiration of gastric contents 289 (13.22) 13 (9.15) 302 (12.97) 0.1624
 Pancreatitis 30 (1.78) 4 (2.82) 43 (1.85) 0.3304
 Trauma or pulmonary contusion 152 (6.95) 2 (1.41) 154 (6.62) 0.0100
 Inhalation 37 (1.69) 4 (2.82) 41 (1.76) 0.3120
 Non cardiogenic shock 124 (5.67) 11 (7.75) 135 (5.80) 0.3055
 Drowning 0 (0.00) 0 (0.00) 0 (0.00) –
 Drug overdose 55 (2.52) 3 (2.11) 58 (2.49) 1.0000
 Blood transfusion 77 (3.52) 6 (4.23) 83 (3.57) 0.6616
 Other risk factors 101 (4.62) 5 (3.52) 106 (4.55) 0.5426
ICU characteristics
 Academic hospital, n (%) 1660 (78.01) 106 (75.71) 1766 (77.87) 0.5267
 % of ICU on hospital beds, median [IQR] 2.60 [1.56–4.17] 2.61 [1.56–4.35] 2.60 [1.56–4.22] 0.7886
 Beds per physician, median [IQR] 4.83 [2.67–10.00] 4.67 [2.67–9.00] 4.83 [2.67–10.00] 0.4145
 Beds per nurse, median [IQR] 1.50 [1.00–2.00] 1.31 [1.00–2.00] 1.50 [1.00–2.00] 0.0511
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patients that received at least 2 days of invasive mechani-
cal ventilation (Table 6). Factors associated with hospital 
mortality in patients with treatment limitations at ICU 
discharge are presented in Additional file 1: Table S5.
Discussion
In the current study, we found that 94% of patients with-
out limitations of life sustaining therapy that were dis-
charged from ICU stay survived to hospital discharge, 
while 61% of patients who had treatment limitations in 
place also survived to hospital discharge. Patients with-
out treatment limitations that died in hospital after ICU 
discharge were older, and more likely to have COPD, 
immunocompromise or chronic renal failure. They were 
less likely to have trauma as a risk factor for ARDS, 
or to receive neuromuscular blockade or any adjunc-
tive measure. An important—and unexpected—find-
ing was that even though these patients were critically 
ill due to ARDS, it was the non-pulmonary components 
of their organ dysfunction that was associated with risk 
of death in hospital following ICU discharge, while the 
derangement of oxygenation at ICU admission was not. 
In addition, our finding that non-survivors received less 
adjunctive therapies than survivors, raises important 
questions on whether the low implementation of these 
measures might contribute to some of the long-term 
ARDS mortality. Understanding the factors associated 
with death in hospital following ICU discharge may allow 
us to focus efforts on these issues in order to improve 
outcomes.
Factors contributing to death post ICU discharge
Our finding of a 6% mortality post ICU discharge in 
patients with acute hypoxaemic respiratory failure is 
at the lower end of a range of 6–25% hospital mortality 
rates reported in ICU survivors in earlier studies [6–8]. 
Fig. 2 Patients with no treatment limitations who die in hospital following ICU discharge have higher overall SOFA scores (a), which appeared to be 
due to higher systemic organ injury severity scores (b) as pulmonary organ injury severity scores (c, d) were similar, compared to survivors, at both 
ICU admission and at ICU discharge
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However, it remains higher than other studies of ICU 
survivors where it has ranged from 3% in patients at risk 
for ARDS to 4% in all ICU patients without limitations in 
life sustaining therapies [9, 10]. In this regard it is impor-
tant to remember that the LUNG SAFE population con-
stitutes a more severely ill patient cohort, with patients 
all fulfilling criteria for severe hypoxaemia requiring 
assisted ventilation.
Identifying risk factors in patients who are likely to 
die in hospital following ICU discharge may allow us to 
focus efforts on these factors (if modifiable) in order to 
improve outcomes, either prior to or following ICU dis-
charge. In this study, we found that patients dying post 
ICU discharge were systemically sicker as indicated 
by non-pulmonary SOFA at ICU discharge. Sepsis is a 
frequent cause of later deaths in patients with ARDS [11], 
which may be consistent with our finding of a higher 
non-pulmonary SOFA score for patients that died post 
ICU discharge. In contrast, pulmonary factors, includ-
ing initial ARDS severity or respiratory status at weaning 
from invasive ventilation, were not associated with hospi-
tal mortality post ICU discharge.
In regard to patient management, patients that received 
either neuromuscular blockade use or the use of any 
adjunct, were more likely to survive post ICU discharge. 
However, this finding needs to be balanced against 
our prior findings showing that ICU survival in patient 
receiving adjunctive therapies was lower [12], raising the 
potential that this finding may reflect an alteration in the 
pattern of patients dying in the ICU versus the wards, 
Table 2 Illness severity in study subpopulation with no treatment limitations at ICU discharge stratified by vital status at hospital 
discharge
ARDS acute respiratory distress syndrome, FiO2 fraction of inspired oxygen, IBW ideal body weight, ICU intensive care unit, IQR interquartile range [first and third 
quartile], PaCO2 partial pressure arterial carbon dioxide, PaO2 partial pressure arterial oxygen, PEEP positive end-expiratory pressure, PIP peak inspiratory pressure, SD 
standard deviation, SOFA sequential organ failure assessment.
Parameter Alive N = 2186 Dead N = 142 Total N = 2328 p value
Illness severity at 1st day of AHRF
ARDS, n (%) 1,242 (56.82) 76 (53.52) 1,318 (56.62) 0.4427
Gas exchange
  PaO2/FiO2 (mmHg), mean ± SD 173.81 ± 66.30 182.49 ± 63.28 174.34 ± 66.14 0.1032
  SpO2 (%), median [IQR] 96.0 [94.0–98.0] 96.0 [94.0–98.0] 96.0 [94.0–98.0] 0.7613
  PaCO2 (mmHg), mean ± SD 45.34 ± 14.88 44.80 ± 14.40 45.31 ± 14.85 0.8351
 pH, mean ± SD 7.35 ± 0.10 7.35 ± 0.10 7.35 ± 0.10 0.9699
Adjusted SOFA scores, mean ± SD 8.33 ± 3.72 9.30 ± 3.58 8.39 ± 3.72 0.0010
Illness severity at last available day in ICU
ARDS, n (%) 132 (7.65) 8 (7.14) 140 (7.62) 0.8452
Gas exchange
  PaO2/FiO2 (mmHg)
  Mean ± SD 259.00 ± 91.83 252.83 ± 86.61 258.58 ± 91.47 0.7798
  Available data, n (%) 1163 (53.20) 85 (59.86) 1248 (53.61) 0.1232
  SpO2 (%)
  Median [IQR] 97.0 [95.0–98.0] 97.0 [95.0–99.0] 97.0 [95.0–98.0] 0.7263
  Available data, n (%) 1381 (63.17) 89 (62.68) 1470 (63.14) 0.9050
  PaCO2 (mmHg)
  Mean ± SD 42.40 ± 10.97 42.01 ± 11.49 42.38 ± 10.99 0.6008
  Available data, n (%) 1265 (57.87) 90 (63.38) 1355 (58.20) 0.1969
 pH (unit)
  Mean ± SD 7.43 ± 0.05 7.43 ± 0.06 7.43 ± 0.06 0.4129
  Available data, n (%) 1271 (58.14) 90 (63.38) 1361 (58.46) 0.2197
Adjusted non-pulmonary SOFA scores, mean ± SD
 Mean ± SD 2.49 ± 2.75 4.08 ± 3.37 2.59 ± 2.82 < .0001
 Available data, n (%) 1337 (61.16) 97 (68.31) 1434 (61.60) 0.0897
Adjusted SOFA scores, mean ± SD
 Mean ± SD 3.87 ± 3.16 5.62 ± 3.71 3.99 ± 3.60 < .0001
 Available data, n (%) 1341(61.34) 97 (68.31) 1438 (61.77) 0.0979
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Table 3 Ventilator setting in patients with no treatment limitations at ICU discharge who received invasive MV for at least 2 days (from 
AHRF onset) stratified by vital status at hospital discharge
FiO2 fraction of inspired oxygen, IBW ideal body weight, IMV invasive mechanical ventilation, IQR interquartile range [first and third quartile], PEEP positive end-
expiratory pressure, PIP peak inspiratory pressure, SD standard deviation
Parameter Alive N = 2186 Dead N = 142 Total N = 2328 p value
Patients on IMV at 1st and 2nd day, n (%) 1545 (70.68) 111 (78.17) 1656 (71.13) 0.0562
 Last day on IMV (with collected data), median [IQR] 7 [3–20] 7 [3–10] 7 [3–10] 0.7307
 Non-invasive Mechanical Ventilation after IMV, n (%) 144 (9.32) 7 (6.31) 151 (9.12) 0.2866
Ventilator setting at 1st day of Invasive MV
 Controlled ventilation, n (%) 1081 (71.21) 76 (69.72) 1157 (7111) 0.7407
  FiO2, median [IQR] 0.60 [0.40–0.80] 0.50 [0.40–0.70] 0.57 [0.40–0.80] 0.1899
 Set respiratory rate (breaths/min), mean ± SD 17.92 ± 5.83 17.66 ± 5.38 17.90 ± 5.80 0.7580
 Total respiratory rate (breaths/min), mean ± SD 19.74 ± 6.14 19.51 ± 5.84 19.73 ± 6.12 0.7573
 Tidal volume (ml/kg IBW), mean ± SD 7.77 ± 1.83 7.78 ± 1.88 7.77 ± 1.84 0.6565
 High tidal volume (> 8 ml/kg IBW), n (%) 543 (36.86) 42 (40.00) 585 (37.07) 0.5203
 Dynamic compliance (ml/cmH2O), mean ± SD 33.35 ± 23.96 32.23 ± 23.04 33.27 ± 23.89 0.2753
 PEEP  (cmH2O), mean ± SD 8.12 ± 3.21 7.40 ± 2.85 8.07 ± 3.19 0.0095
 PIP  (cmH2O), mean ± SD 26.04 ± 7.99 25.50 ± 8.02 26.01 ± 7.99 0.5395
 Plateau pressure measured, n (%) 489 (31.65) 33 (29.73) 522 (31.52) 0.6740
 Plateau pressure  (cmH2O), mean ± SD 21.50 ± 5.62 21.73 ± 6.27 21.52 ± 5.66 0.9205
 Driving pressure  (cmH2O), mean ± SD 13.19 ± 5.03 14.64 ± 5.81 13.28 ± 5.09 0.1699
 Minute ventilation (l/min), mean ± SD 9.32 ± 2.87 9.06 ± 3.07 9.30 ± 2.89 0.1545
 Standardized minute ventilation (l/min), mean ± SD 10.43 ± 4.45 9.96 ± 3.94 10.40 ± 4.42 0.4408
Ventilator setting at last available day of Invasive MV in ICU
 Controlled ventilation, n (%) 384 (25.35) 25 (23.15) 409 (25.20) 0.6112
  FiO2
  Median [IQR] 0.40 [0.35–0.45] 0.40 [0.30–0.40] 0.40 [0.35–0.45] 0.0309
  Available data, n (%) 1501 (97.15) 107 (96.40) 1608 (97.10) 0.5586
 Total respiratory rate (breaths/min)
  Mean ± SD 20.21 ± 12.15 20.91 ± 6.76 20.26 ± 11.86 0.1920
  Available data, n (%) 1499 (97.02) 109 (98.20) 1608 (97.10) 0.7674
 Tidal volume (ml/kg IBW)
  High tidal volume (> 8 ml/kg IBW), n (%) 602 (42.82) 42 (42.00) 644 (42.76) 0.8733
  Mean ± SD 7.95 ± 2.06 7.89 ± 2.04 7.95 ± 2.06 0.9763
  Available data, n (%) 1406 (91.00) 100 (90.09) 1506 (90.94) 0.7461
 Dynamic compliance (ml/cmH2O)
  Mean ± SD 49.39 ± 45.70 48.72 ± 30.39 49.35 ± 44.84 0.1701
  Available data, n (%) 1344 (86.99) 96 (86.49) 1440 (86.96) 0.8790
 PEEP  (cmH2O)
  Mean ± SD 6.66 ± 2.43 6.26 ± 1.95 6.63 ± 2.40 0.0597
  Available data, n (%) 1496 (96.83) 106 (95.50) 1602 (96.74) 0.4043
 PIP  (cmH2O)
  Mean ± SD 20.17 ± 7.16 18.51 ± 7.01 20.06 ± 7.16 0.0079
  Available data, n (%) 1395 (90.29) 99 (89.19) 1494 (90.22) 0.7058
 Minute ventilation (l/min)
  Mean ± SD 9.65 ± 4.08 9.56 ± 3.25 9.64 ± 4.03 0.9026
  Available data, n (%) 1447 (93.66) 103 (92.79) 1550 (93.60) 0.7194
 Standardized minute ventilation (l/min)
  Mean ± SD 10.11 ± 4.93 10.04 ± 4.00 10.10 ± 4.87 0.7355
  Available data, n (%) 1257 (81.36) 92 (82.88) 1349 (81.46) 0.6899
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rather than a true association with improved patient 
outcome.
The duration of ICU stay was similar in patients that 
survived following ICU discharge compared to those 
that died in-hospital, with the proportion of longer 
ICU stay patients significantly higher in survivors. In 
patients with treatment limitations, non-survivors 
actually had shorter ICU stays compared to survi-
vors. This finding appears to rule out the potential for 
patients that die post ICU discharge to have had longer 
durations of critical illness compared to patients that 
survive to hospital discharge.
Fig. 3 Patients with no treatment limitations who die in hospital require comparable or lower degrees of ventilatory support on the last day of 
assisted ventilation in the ICU compared to survivors at ICU discharge. Specifically, last day  FiO2 (a) and peak initiatory pressures (b) were lower, 
while tidal volume, respiratory rates, dynamic compliance and minute volumes (c–f) were similar, in comparison to hospital survivors
Table 4 Adjunctive measures performed during ICU stay in study subpopulation with no treatment limitations at ICU discharge 
stratified by vital status at hospital discharge
ECMO extra corporeal membrane oxygenation, HFOV high frequency oscillatory ventilation
Parameter Alive N = 2186 Dead N = 142 Total N = 2328 p value
Neuromuscular blockade, n (%) 304 (13.91) 8 (5.63) 312 (13.40) 0.0050
Recruitment maneuvers, n (%) 305 (13.95) 14 (9.86) 319 (13.70) 0.1693
Prone positioning, n (%) 100 (4.57) 2 (1.41) 102 (4.38) 0.0741
ECMO, n (%) 30 (1.37) 0 (0.00) 30 (1.29) 0.1600
Inhaled vasodilators, n (%) 126 (5.76) 7 (4.93) 133 (5.71) 0.6781
HFOV, n (%) 27 (1.24) 0 (0.00) 27 (1.16) 0.1828
None of above adjunctive measures, n (%) 1571 (71.87) 116 (81.69) 1687 (72.47) 0.0111
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Impact of limitation of care
Our findings suggest that the likelihood of hospital sur-
vival post-ICU discharge varies greatly depending on 
whether or not treatment limitations are in place. This 
finding is consistent with previous studies showing that 
the presence of limitations of life sustaining therapies is 
the most important factor in predicting death post ICU 
admission [2].
The majority of decisions to limit of life sustaining ther-
apies were made after development of AHRF. Interest-
ingly, hospital survival post ICU discharge in patient with 
a treatment limitation decision was encouragingly high at 
61%, while the timing of placement of treatment limita-
tions didn’t significantly affect the mortality rate.
Increased age and the presence of active or hemato-
logic neoplasm, immune suppression, chronic liver fail-
ure and indices of greater illness severity were associated 
with limitation of care, consistent with prior findings 
[10]. Overall, there were similarities between the factors 
associated with patient outcome, and those associated 
with limitation of care. This may be consistent with the 
fact that death in the ICU frequently occurs in the con-
text of decisions to limit life sustaining therapy due to 
perceived futility [13, 14]. Of interest ARDS recognition 
rates in patients with limitations of care were lower in 
non-survivors compared to survivors, a finding not seen 
in patients with no treatment limitations.
Encouragingly, the majority of patients with treatment 
limitations survived their hospital stay in this cohort. 
This finding is consistent with reports of improved out-
comes for patients with limitations of life sustaining 
therapies in other recent studies. In a prospective obser-
vational study of 22 European ICUs, significantly more 
patients had limitations in life-sustaining therapies, while 
death without limitations in life-sustaining therapies 
occurred significantly less frequently, in 2015–2016 com-
pared with 1999–2000 [3]. Consistent with our findings, 
overall survival in patients with treatment limitations 
was better in the 2015–6 cohort (20.4%) compared to the 
1999–2000 cohort (5.5%). Our findings further suggest 
that, in the patient cohort with treatment limitations that 
survive to ICU discharge, the chances of survival to hos-
pital discharge are quite favourable.
Geo‑economic area
The higher SOFA sores at ICU discharge in patients from 
the Non-European-high income area may be explained 
by their shorter ICU stays [5], given that SOFA scores at 
day 10 post ICU admission were not different across the 
regions. Geo-economic location was not an independ-
ent predictor of survival in hospital post ICU discharge. 
The substantially higher proportion of survival patients 
with treatment limitations in Middle Income countries 
suggests these patients may be different to patients with 
limitations in high income countries, possibly because 
limitations were placed for reasons other than antici-
pated poor prognosis.
Table 5 SOFA Scores and Outcomes in patients with no treatment limitations by major Geo-Economic Area
*p value < 0.05, comparison with European high-income countries








Illness severity at last available day in ICU
 Adjusted non-pulmonary SOFA scores, median [1st–3rd quartile]





















  p value (comparison among areas) < .0001 0.0046 < .0001
Illness severity on Day 10 in ICU
 Adjusted non-pulmonary SOFA scores, median [1st–3rd quartile]





















  p value (comparison among areas) 0.2436 0.3817 0.1790
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Fig. 4 Outcomes of patients that survive to hospital discharge. In a length of ICU stay was similar in patients who survived to hospital discharge 
and those that died, both with and without treatment limitations. In b, hospital survival rates post ICU discharge were significantly lower in patients 
that had treatment limitations, compared to those with no limitations. In c in patients with no limitations, survival was significantly higher in those 
that received adjunctive therapies
Table 6 Factors associated with hospital mortality in patients with no treatment limitations at ICU discharge
Model 1 was identified by stepwise approach using as possible predictors: baseline patients’ characteristics, parameters of illness of severity at last available day in ICU, 
use of adjunctive measures during ICU stay and ICU characteristics. 
Model 2 was identified by stepwise approach using as possible predictors: baseline patients’ characteristics, parameters of illness of severity and ventilator setting at 
last available day in ICU, use of adjunctive measures during ICU stayand ICU characteristics
CI confidence interval, ICU intensive care unit, OR odds ratio, SOFA sequential organ failure assessment
OR (95% CI) p value
Multivariable logistic regression model 1 (n = 1438 on 2328)
 Age (years) 1.044 (1.028–1.061) < .0001
 Adjusted SOFA score at last available day in ICU 1.154 (1.090–1.222) < .0001
 Immune-incompetence (ref. No) 2.086 (1.281–3.397) 0.0031
 Adjunctive measures during ICU stay (ref. No) 0.574 (0.340–0.970) 0.0383
Multivariable logistic regression model on patients on MV for at least 2 days (from AHRF onset) (n = 1043 on 1656)
 Age (years) 1.048 (1.029–1.067) < .0001
 Adjusted SOFA score at last available day in ICU 1.167 (1.091–1.248) < .0001
 Immune-incompetence (ref. No) 1.938 (1.071–3.509) 0.0288
 BMI (kg/m2) 0.954 (0.911–0.999) 0.0469
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Study limitations
There are limitations to this study. Our study focused 
on identifying factors during the ICU stay, and did not 
examine factors following ICU discharge, that were asso-
ciated with death in this population. It would likely have 
yielded further insights into this important area if we 
had collected more detailed data on the status of patients 
post ICU discharge, such as the Sabadell score [15]. We 
do not have data on any decisions made regarding limita-
tion of life supporting measures following ICU discharge. 
However, our aim was to look at factors relating to the 
ICU stay and their impact on mortality post discharge, 
as this is the aspect of care under the control of the ICU 
team. This is not to negate the impact of events following 
ICU discharge on patient outcomes. In this regard, recent 
findings that adverse events occur commonly following 
ICU discharge, and can contribute to death in hospital 
are of particular relevance [16].
We do not have data on whether care-providers insti-
tuted treatment limitations in some patients once dis-
charged from the ICU, nor do we have information on 
where patients were discharged to such as home or nurs-
ing home. We did not record details of the specific life 
supporting measures that were limited, or whether there 
were more than one decision made regarding these meas-
ures during the ICU stay.
This is a secondary and exploratory analysis of LUNG 
SAFE observational study and no prespecified hypoth-
eses on mortality risk after ICU discharge were consid-
ered during study conception. As this was an exploratory 
study, no adjustments were made to significance levels 
for multiple comparison testing.
As this is an observational study, we cannot ascribe 
causation to factors that were associated with better out-
comes including adjunctive measure use. Similar to other 
epidemiologic studies, we did not have access to the 
source data for the patients in the enrolling ICUs, and it 
is possible that some patients with hypoxemia, and thus 
ARDS, in participating centres were missed. It is impor-
tant to stress, however, that ICUs were participating 
whether or not they identified any patient having ARDS 
and that the diagnosis of ARDS was not based on chart 
records. In addition, enrolment of patients with ARDS 
from participating ICUs met expectations based on their 
recorded 2013 admission rates, while data from lower 
recruiting ICUs were not different from higher enroll-
ing ICUs, suggesting the absence of reporting biases. To 
ensure data quality, we instituted a robust data quality 
control program in which all centres were requested to 
verify data that appeared inconsistent or erroneous. The 
absence of data on other aspects of ICU management, 
e.g. fluid therapy, may limit the conclusions that can be 
drawn.
Conclusions
This is the first study to our knowledge examining fac-
tors associated with mortality post ICU discharge in 
patients with ARDS. Encouragingly, survival rates to 
hospital discharge following ICU discharge are high, 
with survival rates in patients with limitations of life 
sustaining therapy higher than expected. An impor-
tant—and unexpected—finding was that even though 
these patients were critically ill due to ARDS, it was the 
non-pulmonary components of their organ dysfunc-
tion that was associated with risk of death in hospital 
following ICU discharge. In addition, our finding that 
non-survivors received less adjunctive therapies than 
survivors, raises important questions.
Focusing attention on this and other factors associ-
ated with death in hospital following ICU discharge 
may allow us to further improve outcomes in these 
patients.
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(Clermont-Ferrand): Jean-Michel Constantin, Sandrine Thibault; CHI Eure-Seine 
Evreux (Evreux): Mohammed Ghazi, Messabi Boukhazna; Centre Hospitalier 
de Châlons en Champagne (Châlons en Champagne): Salem Ould Zein; CH 
Beauvais (Beauvais): Jack R Richecoeur, Daniele M Combaux; Centre Hospitalier 
Le Mans (Le Mans): Fabien Grelon, Charlene Le Moal; Hôpital Fleyriat (Bourg 
en Bresse): Elise P Sauvadet, Adrien Robine; Hôpital Saint Louis (Paris): Virginie 
Lemiale, Danielle Reuter; Pneumologie et Réanimation Médicale, Hôpital 
Pitié-Salpêtrière (Paris): Martin Dres, Alexandre Demoule; Centre Hospitalier 
Gonesse (Gonesse): Dany Goldgran-Toledano; Hôpital Croix Rousse (Lyon): 
Loredana Baboi, Claude Guérin;
Germany: St. Nikolaus-Stiftshospital (Andernach): Ralph Lohner; 
Fachkrankenhaus Coswig Gmbh (Coswig):Jens Kraßler, Susanne Schäfer; 
University Hospital Frankfurt (Frankfurt am Main): Kai D Zacharowski, Patrick 
Meybohm; Department of Anaesthesia & Intensive Care Medicine, University 
Hospital of Leipzig (Leipzig): Andreas W Reske, Philipp Simon; Asklepios Klinik 
Langen (Langen): Hans-Bernd F Hopf, Michael Schuetz; Städtisches Kranken-
haus Heinsberg (Heinsberg): Thomas Baltus;
Greece: Hippokrateion General Hospital Of Athens (Athens): Metaxia 
N Papanikolaou, Theonymfi G Papavasilopoulou; Gh Ahepa (Thessaloniki): 
Giannis A Zacharas, Vasilis Ourailogloy; Hippokration General Hospital of Thes-
saloniki (Thessaloniki): Eleni K Mouloudi, Eleni V Massa; Hospital General of 
Kavala (Kavala): Eva O Nagy, Electra E Stamou; Papageorgiou General Hospital 
(Thessaloniki): Ellada V Kiourtzieva, Marina A Oikonomou;
Guatemala: Hospital General De Enfermedades, Instituto Guatemalteco 
De Seguridad Social (Ciudad De Guatemala): Luis E Avila; Centro Médico 
Militar (Guatemala): Cesar A Cortez, Johanna E Citalán;
India: Deenanath Mangeshkar Hospital And Research Center (Pune): 
Sameer A Jog, Safal D Sable; Care Institute Of Medical Sciences (CIMS) Hospital 
(Ahmedabad): Bhagyesh Shah; Sanjay Gandhi Postgraduate Institute Of Medi-
cal Sciences (SGPGIMS) (Lucknow): Mohan Gurjar, Arvind K Baronia; Rajasthan 
Hospital (Ahmedabad): Mohammedfaruk Memon; National Institute Of Mental 
Health And Neuro Sciences (NIMHANS) (Bangalore): Radhakrishnan Muth-
uchellappan, Venkatapura J Ramesh; Anaesthesiology Unit of the Kasturba 
Medical College & Dept of Respiratory Therapy, SHOAS, Manipal University 
(Manipal): Anitha Shenoy, Ramesh Unnikrishnan; Sanjeevan Hospital (Pune): 
Subhal B Dixit, Rachana V Rhayakar; Apollo Hospitals (Chennai): Nagarajan 
Ramakrishnan, Vallish K Bhardwaj; Medicine Unit of the Kasturba Medical 
College & Dept of Respiratory Therapy, SHOAS, Manipal University (Manipal): 
Heera L Mahto, Sudha V Sagar; G Kuppuswamy Naidu Memorial Hospital 
(Coimbatore): Vijayanand Palaniswamy, Deeban Ganesan;
Iran: NRITLD/Masih Daneshvari (Tehran): Seyed Mohammadreza 
Hashemian, Hamidreza Jamaati ; Milad Hospital (Tehran): Farshad Heidari
Ireland: St Vincent’s University Hospital (Dublin): Edel A Meaney, Alistair 
Nichol; Mercy University Hospital (Cork): Karl M Knapman, Donall O’Croinin 
; Cork University Hospital (Cork): Eimhin S Dunne, Dorothy M Breen; Galway 
University Hospital (Galway): Kevin P Clarkson, Rola F Jaafar; Beaumont Hos-
pital (Dublin): Rory Dwyer, Fahd Amir; Mater Misericordiae University Hospital 
(Dublin): Olaitan O Ajetunmobi, Aogan C O’Muircheartaigh; Tallaght Hospital 
(Dublin): Colin S Black, Nuala Treanor; Saint James’s Hospital (Dublin): Daniel V 
Collins, Wahid Altaf;
Italy: Santa Maria delle Croci Hospital (Ravenna): Gianluca Zani, Maurizio 
Fusari; Arcispedale Sant’Anna Ferrara. (Ferrara): Savino Spadaro, Carlo A Volta; 
Ospedale Profili (Fabriano) (An): Romano Graziani, Barbara Brunettini; Umberto 
I Nocera Inferiore (Nocera Inferiore Salerno): Salvatore Palmese; Azienda Ospe-
daliera San Paolo—Polo Universitario- Università degli Studi di Milano (Milan): 
Paolo Formenti, Michele Umbrello; Sant’Anna (San Fermo Della Battaglia (Co)): 
Andrea Lombardo; Spedali Civili Brescia (Brescia): Elisabetta Pecci, Marco Bot-
teri; Fondazione Irccs Ca Granda, Ospedale Maggiore Policlinico (Milan): Mon-
ica Savioli, Alessandro Protti; University Campus Bio-Medico of Rome (Rome): 
Alessia Mattei, Lorenzo Schiavoni; Azienda Ospedaliera “Mellino Mellini" (Chiari 
(Bs)): Andrea Tinnirello, Manuel Todeschini; Policlinico P. Giaccone, University 
of Palermo (Palermo): Antonino Giarratano, Andrea Cortegiani; Niguarda Cà 
Granda Hospital (Milan): Sara Sher, Anna Rossi; A.Gemelli University Hospital 
(Rome): Massimo M Antonelli, Luca M Montini; Ospedale “Sandro Pertini” 
(Rome): Paolo Casalena, Sergio Scafetti; ISMeTT IRCCS UPMC (Palermo): Gio-
vanna Panarello, Giovanna Occhipinti; Ospedale San Gerardo (Monza): Nicolò 
Patroniti, Matteo Pozzi; Santa Maria Della Scaletta (Imola): Roberto R Biscione, 
Michela M Poli; Humanitas Research Hospital (Rozzano): Ferdinando Raimondi, 
Daniela Albiero;Ospedale Desio—Ao Desio-Vimercate (Desio): Giulia Crapelli, 
Eduardo Beck; Pinetagrande Private Hospital (Castelvolturno): Vincenzo Pota, 
Vincenzo Schiavone; Irccs San Martino Ist (Genova): Alexandre Molin, Fabio Tar-
antino; Ospedale San Raffaele (Milano): Giacomo Monti, Elena Frati; Ospedali 
Riuniti Di Foggia (Foggia): Lucia Mirabella, Gilda Cinnella; Azienda Ospedaliera 
Luigi Sacco—Polo Universitario (Milano): Tommaso Fossali, Riccardo Colombo; 
A.O.U. Città della Salute e della Scienza di Torino (Turin): Pierpaolo Terragni 
Ilaria Pattarino; Università degli Studi di Pavia-Fondazione IRCCS Policlinico 
San Matteo (Pavia): Francesco Mojoli, Antonio Braschi; Ao Ospedale Civile 
Legnano (Legnano): Erika E Borotto; Arnas Ospedale Civico Di Cristina Benfra-
telli (Palermo): Andrea N Cracchiolo, Daniela M Palma; Azienda Ospedaliera 
Della Provincia Di Lecco—Ospedale "A. Manzoni" (Lecco): Francesco Raponi, 
Giuseppe Foti; A.O. Provincia Di Lecco—Ospedale Alessandro Manzoni 
(Lecco): Ettore R Vascotto, Andrea Coppadoro; Cliniche Universitarie Sassari 
(Sassari): Luca Brazzi, Leda Floris; IRCCS Policlinico San Matteo (Pavia): Giorgio 
A Iotti, Aaron Venti;
Japan: Yokohama City University Hospital (Yokohama): Osamu Yama-
guchi, Shunsuke Takagi; Toyooka Hospital (Toyooka City,Hyogo Prefecture): 
Hiroki N Maeyama; Chiba University Hospital (Chiba City): Eizo Watanabe, 
Yoshihiro Yamaji; Okayma University Hospital (Okayama): Kazuyoshi Shimizu, 
Kyoko Shiozaki; Japanese Foundation for Cancer Research, Cancer Institute 
Hospital, Department Of Emergency Medicine And Critical Care (Tokyo): 
Satoru Futami; Ibaraki Prefectural Central Hospital (Kasama): Sekine Ryosuke; 
Tohoku University Hospital (Sendai-Shi): Koji Saito, Yoshinobu Kameyama; 
Tokyo Medical University Hachioji Medical Center (Hachioji, Tokyo): Keiko 
Ueno; Tokushima University Hospital (Tokushima): Masayo . Izawa, Nao Okuda; 
Maebashi Red Cross Hospital (Gunma Maebashi): Hiroyuki Suzuki, Tomofumi 
Harasawa; Urasoe General Hospital (Urasoe): Michitaka Nasu, Tadaaki Takada; 
Ohta General Hospital Foundation Ohta Nishinouchi Hospital (Fukushima): 
Fumihito Ito; Jichi Medical University Hospital (Shimotsuke): Shin—Nunomiya, 
Kansuke—Koyama; Mito Kyodo General Hospital, Tsukuba University Hospital 
Mito Medical Center (Mito): Toshikazu Abe; Sendai City Hospital (Sendai): Koh-
kichi Andoh, Kohei Kusumoto; Ja Hiroshima General Hospital (Hatsukaichi City, 
Hiroshima): Akira Hirata, Akihiro Takaba; Yokohama Rosai Hospital (Yokohama): 
Hiroyasu Kimura; Nagasaki University Hospital (Nagasaki): Shuhei Matsumoto, 
Ushio Higashijima; Niigata University Medical & Dental Hospital (Niigata): 
Hiroyuki Honda, Nobumasa Aoki; Mie University Hospital (Tsu, Mie): Hiroshi 
Imai; Yamaguchi University Hospital (Ube, Yamaguchi): Yasuaki Ogino, Ichiko 
Mizuguchi; Saiseikai Kumamoto Hospital (Kumamoto City): Kazuya Ichikado; 
Shinshu University School Of Medecine (Matsumoto City): Kenichi Nitta, Katsu-
nori Mochizuki; Kuki General Hospital (Kuki): Tomoaki Hashida; Kyoto Medical 
Center (Kyoto): Hiroyuki Tanaka ; Fujita Health University (Toyoake): Tomoyuki 
Nakamura, Daisuke Niimi; Rakwakai Marutamachi Hospital (Kyoto): Takeshi 
Ueda; Osaka University Hospital (Suita City, Osaka Prefecture): Yozo Kashiwa, 
Akinori Uchiyama;
Latvia: Paul Stradins Clinical University Hospital (Riga): Olegs Sabelnikovs 
, Peteris Oss ;
Lebanon: Kortbawi Hospital (Jounieh): Youssef Haddad;
Malaysia: Hospital Kapit (Kapit): Kong Y Liew;
Mexico: Instituto Nacional De Cancerología, México (Mexico City): Silvio A 
Ñamendys-Silva, Yves D Jarquin-Badiola; Hospital De Especialidades “Antonio 
Fraga Mouret” Centro Medico Nacional La Raza IMSS (Mexico City): Luis A 
Sanchez-Hurtado, Saira S Gomez-Flores; Hospital Regional 1° De Octubre 
(Mexico City): Maria C Marin, Asisclo J Villagomez; Hospital General Dr Manuel 
Gea Gonzalez (Mexico City): Jordana S Lemus, Jonathan M Fierro; Hospital 
General De Zona No. 1 Instituto Mexicano Del Seguro Social Tepic Nayarit 
(Tepic): Mavy Ramirez Cervantes, Francisco Javier Flores Mejia; Centro Medico 
Dalinde (Mexico D.F.): Dulce Dector, Dulce M Dector; Opd Hospital Civil De 
Guadalajara Hospital Juan I Menchaca (Guadalajara): Daniel R Gonzalez, Clau-
dia R Estrella; Hospital Regional De Ciudad Madero Pemex (Ciudad Madero): 
Jorge R Sanchez-Medina, Alvaro Ramirez-Gutierrez; Centro Médico ABC 
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(Mexico D.F.): Fernando G George, Janet S Aguirre; Hospital Juarez De Mexico 
(Mexico City): Juan A Buensuseso, Manuel Poblano;
Morocco: Mohammed V University, University Teaching Ibn Sina Hospital 
(Rabat): Tarek Dendane, Amine Ali Zeggwagh; Hopital Militaire D’Instruction 
Mohammed V (Rabat): Hicham Balkhi; Errazi (Marrakech): Mina Elkhayari, 
Nacer Samkaoui; University Teaching Hospital Ibn Rushd (Casablanca): Hanane 
Ezzouine, Abdellatif Benslama; Hôpital des Spécialités de Rabat (HSR) (Rabat): 
Mourad Amor, Wajdi Maazouzi;
Netherlands: Tjongerschans (Heerenveen): Nedim Cimic, Oliver Beck; Cwz 
(Nijmegen): Monique M Bruns, Jeroen A Schouten; Rijnstate Hospital (Arn-
hem): Myra—Rinia, Monique Raaijmakers; Radboud Umc (Nijmegen): Leo M 
Heunks, Hellen M Van Wezel; Maastricht University Medical Centre (Maastricht): 
Serge J Heines, Ulrich Strauch; Catharinaziekenhuis (Eindhoven): Marc P Buise; 
Academic Medical Center (Amsterdam): Fabienne D Simonis, Marcus J Schultz;
New Zealand: Tauranga Hospital (Tauranga): Jennifer C Goodson, Troy S 
Browne; Wellington Hospital (Wellington): Leanlove Navarra, Anna Hunt; Dun-
edin Hospital (Dunedin): Robyn A Hutchison, Mathew B Bailey; Auckland City 
Hospital (Auckland): Lynette Newby, Colin Mcarthur; Whangarei Base Hospital 
(Whangarei): Michael Kalkoff, Alex Mcleod; North Shore Hospital (Auckland): 
Jonathan Casement, Danielle J Hacking;
Norway: Ålesund Hospital (Ålesund): Finn H Andersen, Merete S Dolva; 
Oslo University Hospital—Rikshospitalet Medical Centre (Oslo): Jon H Laake, 
Andreas Barratt-Due; Stavanger University Hospital (Stavanger): Kim Andre L 
Noremark, Eldar Søreide; Haukeland University Hospital (Bergen): Brit Å Sjøbø, 
Anne B Guttormsen;
Peru: Hospital Nacional Edgardo Rebagliati Martins (Lima): Hector H 
Leon Yoshido; Clínica Ricardo Palma (Lima): Ronald Zumaran Aguilar, Fredy A 
Montes Oscanoa;
Philippines: The Medical City (Pasig): Alain U Alisasis, Joanne B Robles; 
Chong Hua Hospital (Cebu): Rossini Abbie B Pasanting-Lim, Beatriz C Tan;
Poland: Warsaw University Hospital (Warsaw): Pawel Andruszkiewicz, 
Karina Jakubowska;
Portugal: Centro Hospitalar Da Cova Da Beira (Covilhã): Cristina M Coxo; 
Hospital Santa Maria, Chln (Lisboa): António M Alvarez, Bruno S Oliveira; Centro 
Hospitalar Trás-Os-Montes E Alto Douro—Hospital De S.Pedro -Vila Real (Vila 
Real): Gustavo M Montanha, Nelson C Barros; Hospital Beatriz Ângelo (Loures): 
Carlos S Pereira, António M Messias; Hospital De Santa Maria (Lisboa): Jorge 
M Monteiro; Centro Hospitalar Médio Tejo—Hospital De Abrantes (Abrantes): 
Ana M Araujo, Nuno T Catorze; Instituto Português De Oncologia De Lisboa 
(Lisboa): Susan M Marum, Maria J Bouw; Hospital Garcia De Orta (Almada): 
Rui M Gomes, Vania A Brito; Centro Hospitalar Do Algarve (Faro): Silvia Castro, 
Joana M Estilita; Hpp Hospital De Cascais (Alcabideche): Filipa M Barros; 
Hospital Prof. Doutor Fernando Fonseca Epe (Amadora): Isabel M Serra, Aurelia 
M Martinho;
Romania: Fundeni Clinical Institute (Bucharest): Dana R Tomescu, Alexan-
dra Marcu; Emergency Clinical County Hospital Timisoara (Timisoara): Ovidiu H 
Bedreag, Marius Papurica; Elias University Emergency Hospital (Bucharest): Dan 
E Corneci, Silvius Ioan Negoita;
Russian Federation: University Hospital (Kemerovo): Evgeny Grigoriev 
;Krasnoyarsk Regional Hospital, Krasnoyarsk State Medical University (Krasno-
yarsk): Alexey I Gritsan, Andrey A Gazenkampf;
Saudi Arabia: GICU of PSMMC (Riyadh): Ghaleb Almekhlafi, Mohamad M 
Albarrak; SICU of PSMMC (Riyadh): Ghanem M Mustafa;; King Faisal Hospital 
And Research Center (Riyadh): Khalid A Maghrabi, Nawal Salahuddin; King 
Fahad Hospital (Baha): Tharwat M Aisa; King Abdulaziz Medical City (Riyadh): 
Ahmed S Al Jabbary, Edgardo Tabhan; King Abdulaziz Medical City (Riyadh): 
Yaseen M Arabi; King Abdulaziz Medical City (Riyadh): Yaseen M Arabi, Olivia 
A Trinidad; King Abdulaziz Medical City (Riyadh): Hasan M Al Dorzi, Edgardo E 
Tabhan;
South Africa: Charlotte Maxeke Johannesburg Academic Hospital (Johan-
nesburg): Stefan Bolon, Oliver Smith;
Spain: Hospital Sant Pau (Barcelona): Jordi Mancebo, Hernan Aguirre-
Bermeo; Hospital Universitari Bellvitge (L Hospitalet De Llobregat (Barcelona)): 
Juan C Lopez-Delgado, Francisco Esteve; Hospital Son Llatzer (Palma De 
Mallorca): Gemma Rialp, Catalina Forteza; Sabadell Hospital, CIBER Enferme-
dades Respiratorias (Sabadell): Candelaria De Haro, Antonio Artigas; Hospital 
Universitario Central De Asturias (Oviedo): Guillermo M Albaiceta, Sara De 
Cima-Iglesias; Complejo Hospitalario Universitario A Coruña (A Coruña): 
Leticia Seoane-Quiroga, Alexandra Ceniceros-Barros; Hospital Universitario 
Miguel Servet (Zaragoza): Antonio L Ruiz-Aguilar, Luis M Claraco-Vega; Morales 
Meseguer University Hospital (Murcia): Juan Alfonso Soler, Maria del Carmen 
Lorente; Hospital Universitario del Henares(Coslada): Cecilia Hermosa, Federico 
Gordo; Complejo Asistencial De Palencia. Hospital Rio Carrión (Palencia): 
Miryam—Prieto-González, Juan B López-Messa; Fundación Jiménez Díaz 
(Madrid): Manuel P Perez, Cesar P Perez; Hospital Clínico Universitario Lozano 
Blesa (Zaragoza): Raquel Montoiro Allue; Hospital Verge de la Cinta (Tortosa): 
Ferran Roche-Campo, Marcos Ibañez-Santacruz; Hospital Universitario 12 
De Octubre (Madrid): Susana—Temprano; Hospital Universitario Príncipe 
De Asturias (Alcalá De Henares, Madrid): Maria C Pintado, Raul De Pablo; 
Hospital Universitari Germans Trias I Pujol (Badalona): Pilar Ricart Aroa Gómez; 
Hospital Universitario Arnau De Vilanova De Lleida (Lleida): Silvia Rodriguez 
Ruiz, Silvia Iglesias Moles; Cst Terrassa (Barcelona): Mª Teresa Jurado, Alfons 
Arizmendi; Hospital Universitari Mútua Terrassa (Terrassa): Enrique A Piacentini; 
Hospital Universitario De Móstoles (Mostoles): Nieves Franco, Teresa Honrubia; 
Complejo Asistencial De Salamanca (Salamanca): Meisy Perez Cheng, Elena 
Perez Losada; Hospital General Universitario De Ciudad Real (Ciudad Real): 
Javier—Blanco, Luis J Yuste; Torrecardenas (Almeria): Cecilia Carbayo-Gorriz, 
Francisca G Cazorla-Barranquero; Hospital Universitario Donostia (San 
Sebastian): Javier G Alonso, Rosa S Alda; Hospital Universitario De Torrejón 
(Madrid): Ángela Algaba, Gonzalo Navarro; Hospital Universitario De La Princ-
esa (Madrid): Enrique Cereijo, Esther Diaz-Rodriguez; Hospital Universitario 
Lucus Augusti (Lugo): Diego Pastor Marcos, Laura Alvarez Montero; Hospital 
Universitario Santa Lucia (Cartagena): Luis Herrera Para, Roberto Jimenez 
Sanchez; Hospital Universitario Severo Ochoa, Leganes (Madrid): Miguel Angel 
Blasco Navalpotro, Ricardo Diaz Abad; University Hospital Of Ntra. Sra. De 
Candelaria (Santa Cruz De Tenerife): Raquel Montiel Gonz á lez, D á cil Parrilla 
Toribio; Hospital Universitario Marques De Valdecilla (Santander): Alejandro 
G Castro, Maria Jose D Artiga; Hospital Infanta Cristina (Parla, Madrid): Oscar 
Penuelas ; Hospital General De Catalunya (Sant Cugat Del Valles): Tomas P 
Roser, Moreno F Olga; San Pedro De Alcántara (Cáceres): Elena Gallego Curto, 
Rocío Manzano Sánchez; Sant Joan De Reus (Reus): Vallverdu P Imma, Garcia 
M Elisabet; Hospital Joan XXIII (Tarragona): Laura Claverias, Monica Magret; 
Hospital Universitario De Getafe (Madrid): Ana M Pellicer, Lucia L Rodriguez; 
Hospital Universitario Río Hortega (Valladolid): Jesús Sánchez-Ballesteros, 
Ángela González-Salamanca; Hospital Arquitecto Marcide (Ferrol,La Coruña): 
Antonio G Jimenez, Francisco P Huerta; Hospital General Universitario Grego-
rio Marañón (Madrid): Juan Carlos J Sotillo Diaz, Esther Bermejo Lopez;Hospital 
General De Segovia (Segovia): David D Llinares Moya, Alec A Tallet Alfonso; 
Hospital General Universitario Reina Sofia (Murcia): Palazon Sanchez Eugenio 
Luis, Palazon Sanchez Cesar; Complejo Hospitalario Universitario De Albacete 
(Albacete): Sánchez I Rafael, Corcoles G Virgilio; Hospital Infanta Elena (Valde-
moro): Noelia N Recio;
Sweden: Sahlgrenska University Hospital (Gothenburg): Richard O 
Adamsson, Christian C Rylander; Karolinska University Hospital (Stockholm): 
Bernhard Holzgraefe, Lars M Broman; Akademiska Sjukhuset Uppsala (Upp-
sala): Joanna Wessbergh, Linnea Persson; Vrinnevisjukhuset (Norrköping): 
Fredrik Schiöler, Hans Kedelv; Linkoping University Hospital (Linköping): Anna 
Oscarsson Tibblin, Henrik Appelberg; Skellefteå Lasarett (Skellefteå): Lars 
Hedlund, Johan Helleberg; Karolinska University Hospital Solna (Stockholm): 
Karin E Eriksson, Rita Glietsch; Umeå University Hospital (Umeå): Niklas Larsson, 
Ingela Nygren; Danderyd Hospital (Stockholm): Silvia L Nunes, Anna-Karin 
Morin; Lund University Hospital (Lund): Thomas Kander, Anne Adolfsson;
Switzerland: Chuv (Centre Hospitalier Universitaire Vaudois) (Lausanne): 
Lise Piquilloud; Hôpital neuchâtelois—La Chaux-De-Fonds (La Chaux-De-
Fonds): Hervé O. Zender, Corinne Leemann-Refondini;
Tunisia: Hopital Taher Sfar Mahdia (Mahdia): Souheil Elatrous; University 
Hospital Farhat Hached Sousse (Sousse): Slaheddine Bouchoucha, Imed 
Chouchene; CHU F.Bourguiba (Monastir): Islem Ouanes; Mongi Slim University 
Hospital, La Marsa (La Marsa): Asma Ben Souissi, Salma Kamoun;
Turkey: Cerrahpasa Medical Faculty Emergency Intensive Care Unit 
(Istanbul): Oktay Demirkiran; Cerrahpasa Medical Faculty Sadi Sun Intensive 
Care Unit (Istanbul) : Mustafa Aker, Emre Erbabacan; Uludag University Medical 
Faculty (Bursa): Ilkay Ceylan, Nermin Kelebek Girgin; Ankara University Faculty 
of Medicine, Reanimation 3nd level ICU (Ankara): Menekse Ozcelik, Necmet-
tin Ünal; Ankara University Faculty of Medicine, 2nd level ICU-postoperative 
ICU (Ankara): Basak Ceyda Meco; Istanbul Kartal Egitim Ve Arastirma Hastanesi 
(Istanbul): Onat O Akyol, Suleyman S Derman;
United Kingdom: Papworth Hospital (Cambridge): Barry Kennedy, Ken 
Parhar; Royal Glamorgan Hospital (Llantrisant): Latha Srinivasa; Royal Victoria 
Hospital-Belfast (Belfast): Lia McNamee, Danny McAuley; Jack Steinberg ICU of 
the King’s College (London): Phil Hopkins, Clare Mellis; Frank Stansil ICU of the 
King’s College Hospital (London): Vivek Kakar; ;Liver ICU of the King’s College 
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(London): Dan Hadfield; Christine Brown ICU of the King’s College (London): 
Andre Vercueil; West Suffolk Hospital (Bury St Edmunds): Kaushik Bhowmick, 
Sally K Humphreys; Craigavon Area Hospital (Portadown): Andrew Ferguson, 
Raymond Mckee; Barts Health NHS Trust, Whipps Cross Hospital (Leytonstone): 
Ashok S Raj, Danielle A Fawkes; Kettering General Hospital, Foundation NHS 
Trust (Northamptonshire): Philip Watt, Linda Twohey; Barnet General Hospital 
(Barnet): Rajeev R JhaMatthew Thomas, Alex Morton, Varsha Kadaba; Rother-
ham General Hospital (Rotherham): Mark J Smith, Anil P Hormis; City Hospital, 
(Birmingham): Santhana G Kannan, Miriam Namih; Poole Hospital NHS 
Foundation Trust (Poole): Henrik Reschreiter, Julie Camsooksai; Weston General 
Hospital (Weston-Super-Mare): Alek Kumar, Szabolcs Rugonfalvi; Antrim Area 
Hospital (Antrim): Christopher Nutt, Orla Oneill; Aintree University Hospital 
(Liverpool): Colette Seasman, Ged Dempsey; Northern General Hospital (Shef-
field): Christopher J Scott, Helen E Ellis; John Radcliffe Hospital (Oxford): Stuart 
Mckechnie, Paula J Hutton; St Georges Hospital (London): Nora N Di Tomasso, 
Michela N Vitale; Hillingdon Hospital (Uxbridge): Ruth 0 Griffin, Michael N 
Dean; The Royal Bournemouth & Christchurch NHS Foundation Trust (Bourne-
mouth, Dorset): Julius H Cranshaw, Emma L Willett; Guys And St Thomas 
NHS Foundation Trust (London): Nicholas Ioannou, Gstt Severe Respiratory 
Failure Service ; Whittington Hospital (London): Sarah Gillis; Wexham Park 
Hospital (Slough): Peter Csabi; Western General Hospital (Edinburgh): Rosaleen 
Macfadyen, Heidi Dawson; Royal Preston Hospital (Preston): Pieter D Preez, 
Alexandra J Williams; Brighton And Sussex University Hospitals NHS Trust 
(Brighton): Owen Boyd, Laura Ortiz-Ruiz De Gordoa; East And North Herts NHS 
Trust (Stevenage): Jon Bramall, Sophie Symmonds; Barnsley Hospital (Barnsley): 
Simon K Chau, Tim Wenham; Prince Charles Hospital (Merthyr Tydfil): Tamas 
Szakmany, Piroska Toth-Tarsoly; University Hospital Of South Manchester NHS 
Foundation Trust (Manchester): Katie H Mccalman, Peter Alexander; Harrogate 
District Hospital (Harrogate): Lorraine Stephenson, Thomas Collyer; East And 
North Herts NHS Trust (Welwyn Garden City): Rhiannon Chapman, Raphael 
Cooper; Western Infirmary (Glasgow): Russell M Allan, Malcolm Sim; Dumfries 
And Galloway Royal Infirmary (Dumfries): David W Wrathall, Donald A Irvine; 
Charing Cross Hospital (London): Kim S Zantua, John C Adams; Worcestershire 
Royal Hospital (Worcester): Andrew J Burtenshaw, Gareth P Sellors; Royal 
Liverpool University Hospital (Liverpool): Ingeborg D Welters, Karen E Williams; 
Royal Alexandra Hospital (Glasgow): Robert J Hessell, Matthew G Oldroyd; 
Morriston Hospital (Swansea): Ceri E Battle, Suresh Pillai; Frimley Park Hospital 
(Frimley): Istvan—Kajtor, Mageswaran—Sivashanmugavel; Altnagelvin Hos-
pital (Derry): Sinead C Okane, Adrian Donnelly; Buckinghamshire Healthcare 
NHS Trust (High Wycombe, Buckinghamshire): Aniko D Frigyik, Jon P Careless; 
Milton Keynes Hospital (Milton Keynes): Martin M May, Richard Stewart; Ulster 
Hospital (Belfast): T John Trinder, Samantha J Hagan; University Hospital of 
Wales (Cardiff ):  Jade M Cole; Freeman Hospital (Newcastle Upon Tyne): Caro-
line C MacFie, Anna T Dowling;
Uruguay: Hospital Español (Montevideo): Javier Hurtado, Nicolás Nin; 
Cudam (Montevideo): Javier Hurtado; Sanatorio Mautone (Maldonado): 
Edgardo Nuñez ; Sanatorio Americano (Montevideo): Gustavo Pittini, Ruben 
Rodriguez; Hospital De Clínicas (Montevideo): María C Imperio, Cristina Santos; 
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